WELL, GOOD: Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs.

Eli Lilly on Tuesday said it will spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of the company’s pipeline of so-called small molecule drugs, including its closely watched experimental obesity pill.

It is the second in a string of new planned U.S. investments by the drugmaker. Eli Lilly announced in February that it would spend at least $27 billion to build four new domestic manufacturing plants, adding to $23 billion in previous investments since 2020.

Eli Lilly said it will announce the two remaining U.S. sites this year. The company expects to begin making medicines at all four facilities within five years.

We need to re-shore production of the basics, too.